Clinical Trial Update: First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of First Strike and Second Strike therapies for high-risk metastatic castration-sensitive prostate cancer, sponsored by H. Lee Mof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• First Strike
• Second Strike

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer, Stage IV Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING